SCHEMBL2296243

SCHEMBL2296243

CCc1cc(CC)c(OCc2ccccc2C=O)c(CC)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
HTT P42858 2/20 0.39
HPGD P15428 1/20 0.39
KMT2A Q03164 2/20 0.38
TDP1 Q9NUW8 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
CDK4 P11802 1/20 0.38
CCND1 P24385 1/20 0.38
GAA P10253 1/20 0.35
LMNA P02545 2/20 0.35
THRB P10828 2/20 0.35
MEN1 O00255 1/20 0.35
BLM P54132 1/20 0.35
NPC1 O15118 3/20 0.35
RAB9A P51151 3/20 0.35
MAPT P10636 2/20 0.35
TSHR P16473 1/20 0.34
THRA P10827 1/20 0.33
PTGDR2 Q9Y5Y4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1539550 0.87 ALDH1A1 (0.43) ALDH1A1SMN1; SMN2HTTHPGDKMT2A
SCHEMBL2291294 0.84 THRB (0.36) ALDH1A1SMN1; SMN2HTTHPGDKMT2A
SCHEMBL1539525 0.82 L3MBTL1 (0.45) ALDH1A1SMN1; SMN2HTTHPGDKMT2A
SCHEMBL2289815 0.82 PTGER4 (0.38) ALDH1A1SMN1; SMN2HTTHPGDKMT2A
SCHEMBL2290712 0.80 GABRA1 (0.36) ALDH1A1SMN1; SMN2HTTHPGDKMT2A
SCHEMBL1539478 0.80 MAPT (0.50) ALDH1A1SMN1; SMN2HPGDKMT2ATDP1
SCHEMBL2287854 0.80 ALDH1A1 (0.40) ALDH1A1SMN1; SMN2HTTHPGDKMT2A
SCHEMBL2292237 0.79 SOD1 (0.50) ALDH1A1SMN1; SMN2TDP1L3MBTL1CDK4
SCHEMBL1539441 0.79 L3MBTL1 (0.45) ALDH1A1SMN1; SMN2HTTHPGDKMT2A
SCHEMBL2293056 0.78 MAPT (0.45) ALDH1A1SMN1; SMN2HTTKMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2149545-B1 METHOD FOR PRODUCING BENZALDEHYDE COMPOUND SUMITOMO CHEMICAL CO (JP) 2016-10-05 EP disclosed
CN-101679172-B Method for producing benzaldehyde compound SUMITOMO CO LTD 2013-05-29 CN disclosed
US-7994367-B2 Method for producing benzaldehyde compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-08-09 US disclosed
US-20100210879-A1 METHOD FOR PRODUCING BENZALDEHYDE COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-08-19 US disclosed
CN-101679172-A Method for producing benzaldehyde compound SUMITOMO CHEMICAL CO 2010-03-24 CN disclosed
EP-2149545-A1 METHOD FOR PRODUCING BENZALDEHYDE COMPOUND Sumitomo Chemical Company, Limited (JP) 2010-02-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100210879-A1 METHOD FOR PRODUCING BENZALDEHYDE COMPOUND NQO1, C9, TRPA1 ALDH1A1 83/4885SMN1; SMN2 3093/4885HTT 1687/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.